Topics and Expertise: infectious disease

QBI Coronavirus Research Group races toward a cure

Tue Mar 31, 2020
SARS-COV2 virus particles on human cells
NIH

SARS-COV2 virus particles (orange), which cause COVID-19, on human cells (blue).

The UCSF Quantitative Biosciences Institute has made headway identifying dozens of potential therapies for the COVID-19 outbreak.

Amelia Deitchman, PharmD, PhD

Wed Feb 5, 2020
Deitchman
Assistant Professor

My research seeks to inform novel therapeutic strategies to cure HIV through better understanding of pharmacokinetics and pharmacodynamics of individual and combinations of candidate drugs. Based out of the UCSF Drug Research Unit (DRU), I work with a multidisciplinary team of clinicians-scientists...

MacDougall study finds severe sepsis alert speeds drug delivery

Tue Dec 22, 2015
MacDougall
Elisabeth Fall

Conan MacDougall, PharmD, MAS

Sepsis occurs when the body responds to an infection with a mix of tissue-damaging inflammation and anti-inflammatory responses. This biological storm can lead to acute organ dysfunction (severe sepsis) and dropping blood pressure that does not respond to intravenous fluids (septic shock).

Aweeka co-leads new study of drugs to prevent malaria in young children, pregnant women

Mon Mar 9, 2015
Malaria parasite
Image by Ute Frevert; false color by Margaret Shear

The plasmodium parasite that causes malaria

Francesca Aweeka, PharmD, a faculty member in the School’s Department of Clinical Pharmacy, will co-lead a new five-year, $3.4 million study funded by the National Institutes of Health (NIH) to address one of the world’s most vexing health problems—preventing malaria, especially in the most...